FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: The potential approval of Moderna's mRNA flu vaccine could significantly impact public health initiatives and vaccine availability across Louisiana, particularly in how flu season preparedness is managed by local health departments and medical facilities.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.